[Rate of relapse decreased by highly significant 69%].
D017277:Drug Approval / Q000331:legislation & jurisprudence; D005858:Germany; D006801:Humans; D007116:Immunization, Passive / Q000451:nursing*; D020528:Multiple Sclerosis, Chronic Progressive / Q000451:nursing*; D016896:Treatment Outcome